Antibiotic Drug Push By Administration Could Include BARDA Incubator

As NIH workshop discusses novel approaches to combatting antibiotic resistance from monoclonal antibodies to synthetic stool transplants and antimicrobial peptides, plans are underway to expand BARDA’s focus beyond biodefense.

More from Clinical Trials

More from R&D